Vitura JV to take delivery of first batch of psychedelic medicines by cannabiz team July 26, 2023April 30, 2024 Vitura Health’s first order of MDMA and psilocybin under its joint venture with Canada-based research and […]
CanView sets sights on 2023 milestone as sales continue to rise by Steve Jones June 13, 2023April 30, 2024
Vitura director nets A$6m after selling 14% of his stake in the company by Steve Jones May 25, 2023April 30, 2024
Releaf Group to get own version of CanView in tie-up with Vitura Health by Steve Jones May 16, 2023April 30, 2024
Vitura Health forms JV to distribute and manufacture MDMA and psilocybin in Australia by Steve Jones May 2, 2023April 30, 2024
Company news: MedReleaf; Vitura Health; MGC Pharma; Rua Bioscience by Martin Lane April 13, 2023April 30, 2024
Company news: Vitura Health; Puro; MGC Pharma; Incannex; Cann Global by Steve Jones March 8, 2023April 30, 2024
Company news: Eqalis/Novachem; Cann Group; Vitura Health; Incannex; Lyphe Group by Steve Jones and Martin Lane March 1, 2023April 30, 2024
Vitura Health relishes competition as firm begins ‘phase two’ of growth plan by Steve Jones February 16, 2023April 30, 2024
Vitura Health reports record half as CanView continues to thrive by Martin Lane February 13, 2023February 13, 2023
